Literature DB >> 16139133

Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?

Michael Simons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16139133     DOI： 10.1016/j.jacc.2005.06.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  37 in total

Review 1.  Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statins.

Authors:  Monique Hinchcliff; John Varga
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

2.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

3.  Diabetic monocyte and vascular endothelial growth factor signaling impairment.

Authors:  Michael Simons
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

4.  Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.

Authors:  Mamta Wankhede; Nikita Agarwal; Rodrigo A Fraga-Silva; Casey deDeugd; Mohan K Raizada; S Paul Oh; Brian S Sorg
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

5.  Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.

Authors:  Kazuhide Ishikura; Hirofumi Misu; Masafumi Kumazaki; Hiroaki Takayama; Naoto Matsuzawa-Nagata; Natsumi Tajima; Keita Chikamoto; Fei Lan; Hitoshi Ando; Tsuguhito Ota; Masaru Sakurai; Yumie Takeshita; Kenichiro Kato; Akio Fujimura; Ken-Ichi Miyamoto; Yoshiro Saito; Satomi Kameo; Yasuo Okamoto; Yoh Takuwa; Kazuhiko Takahashi; Hiroyasu Kidoya; Nobuyuki Takakura; Shuichi Kaneko; Toshinari Takamura
Journal:  Diabetologia       Date:  2014-07-03       Impact factor: 10.122

Review 6.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

7.  Endothelial PGC-1α mediates vascular dysfunction in diabetes.

Authors:  Naoki Sawada; Aihua Jiang; Fumihiko Takizawa; Adeel Safdar; Andre Manika; Yevgenia Tesmenitsky; Kyu-Tae Kang; Joyce Bischoff; Hermann Kalwa; Juliano L Sartoretto; Yasutomi Kamei; Laura E Benjamin; Hirotaka Watada; Yoshihiro Ogawa; Yasutomi Higashikuni; Chase W Kessinger; Farouc A Jaffer; Thomas Michel; Masataka Sata; Kevin Croce; Rica Tanaka; Zolt Arany
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

Review 8.  Coronary collateral growth--back to the future.

Authors:  William M Chilian; Marc S Penn; Yuh Fen Pung; Feng Dong; Maritza Mayorga; Vahagn Ohanyan; Suzanna Logan; Liya Yin
Journal:  J Mol Cell Cardiol       Date:  2011-12-19       Impact factor: 5.000

9.  Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis.

Authors:  Vishal C Mehra; Elias Jackson; Xian M Zhang; Xian-Cheng Jiang; Lawrence W Dobrucki; Jun Yu; Pascal Bernatchez; Albert J Sinusas; Gerald I Shulman; William C Sessa; Timur O Yarovinsky; Jeffrey R Bender
Journal:  Am J Pathol       Date:  2014-03-05       Impact factor: 4.307

Review 10.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Authors:  A M Isidori; M A Venneri; D Fiore
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.